Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Preliminary phase II results in for VRI's adjuvanted influenza vaccine

Nov. 28, 1997

WB-2663B, a novel immunosuppressant isolated from Pseudomonas

Nov. 27, 1997

ImmuLogic restructures its operations

Nov. 26, 1997

Role of complement in mast cell-dependent natural immunity

Nov. 24, 1997

Topical FK-506 for skin allograft rejection

Nov. 21, 1997

New cytokine production inhibitors revealed by SS Pharm.

Nov. 21, 1997

FDA advisory committee to review rotavirus vaccine

Nov. 20, 1997

BCH-1393 stimulates CTL response in vitro and in vivo

Nov. 19, 1997

Basiliximab reduces renal allograft rejection in phase III trial

Nov. 19, 1997

Second report of clinical efficacy for rotavirus vaccine

Nov. 18, 1997

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...